Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Cost of Revenue (2016 - 2026)

Ani Pharmaceuticals' Cost of Revenue history spans 14 years, with the latest figure at $100.3 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 24.9% to $100.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $341.3 million, a 36.41% increase, with the full-year FY2025 number at $341.3 million, up 36.41% from a year prior.
  • Cost of Revenue hit $100.3 million in Q4 2025 for Ani Pharmaceuticals, up from $93.4 million in the prior quarter.
  • Over the last five years, Cost of Revenue for ANIP hit a ceiling of $100.3 million in Q4 2025 and a floor of $20.0 million in Q1 2021.
  • Historically, Cost of Revenue has averaged $50.6 million across 5 years, with a median of $45.2 million in 2023.
  • Biggest five-year swings in Cost of Revenue: decreased 8.34% in 2021 and later skyrocketed 71.48% in 2022.
  • Tracing ANIP's Cost of Revenue over 5 years: stood at $33.9 million in 2021, then grew by 7.16% to $36.3 million in 2022, then soared by 47.06% to $53.4 million in 2023, then surged by 50.28% to $80.3 million in 2024, then rose by 24.9% to $100.3 million in 2025.
  • Business Quant data shows Cost of Revenue for ANIP at $100.3 million in Q4 2025, $93.4 million in Q3 2025, and $74.6 million in Q2 2025.